PET scan for Nectin-4 in cancer patients
Part of Cancer, Lungs & breathing, Skin clinical trials.
This trial uses a special PET scan to look for a protein called Nectin-4 in tumors like bladder, breast, and lung cancer. The goal is to see if this imaging can help better detect or monitor these cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have or are suspected to have bladder, breast, or lung cancer
- You can lie still for a PET scan (no severe claustrophobia or fear of radiation)
- You are not pregnant or breastfeeding
- You are willing to use birth control if you could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a special PET/CT scan tracer that is designed to bind to a protein (Nectin-4) found in some bladder cancers. It aims to help doctors see and stage tumors more clearly, which could improve diagnosis and treatment planning.
This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.
This trial is testing a new imaging method using a special tracer (GPA33) to find tumors in people with colorectal, gastric, or pancreatic cancer. It may help doctors see tumors more clearly during a PET scan.
This trial uses a special PET/CT scan that targets a protein on some cancer cells to help detect and evaluate malignant tumors. It may help doctors better map tumors before any cancer treatment starts.
This trial tests a new imaging injection (a radioactive tracer called 68Ga) that sticks to a protein called Nectin-4, which is often found on cancer cells. The goal is to see if this scan can better find tumors in people with certain solid cancers, such as bladder, breast, or lung cancer.
This trial is testing a new radioactive imaging agent that targets a protein called Nectin-4, which is often found on lung tumors. The scan will help doctors see if the tumor is visible and how it spreads, which may guide better treatment decisions for lung cancer patients.
Hear when a new Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.